Searched for
INDEGENE IPO
Sunil Singhania picks stake in Indegene, stock up 4%Indegene shares: Abakkus was one of several institutional investors that participated in the transaction through which private equity giant...- Carlyle hires 5 I-banks for $1 bn Hexaware IPOCarlyle plans to list Hexaware, aiming to raise $1 billion at a valuation of $5.5-6 billion. The move follows Carlyle's acquisition of Hexa...
- Indegene looking forward to enhancing EBITDA & PAT margins: ManagementIndegene's growth plans post IPO include sustaining EBITDA margin growth, retiring loans, and active acquisitions. The company aims to enha...
- Indegene stock debuts with 46% premium over issue priceIndegene's stock debuts at Rs 659.7, a 46% premium over the issue price. The IPO, oversubscribed 70 times, raised funds for debt and capita...
- Indegene IPO shares to debut today. Here's what GMP indicatesIn the unlisted market, Indegene IPO shares are currently trading with a Grey Market Premium (GMP) of Rs 290. Given the upper price band of...
- Indegene IPO allotment likely today: Check status, listing date, GMP and other detailsIndegene IPO Allotment Status: Following a strong response to the IPO, Indegene has completed the share allotment process. The issue was ov...
- Indegene IPO booked over 10x so far on Day 3. Check subscription, GMP and other detailsIndegene IPO GMP: On the final day of the initial public offer (IPO), Indegene was booked a little over 10 times so far on Wednesday, the l...
- Indegene IPO booked over 4x so far on Day 2. Check subscription, GMP and other detailsIndegene's IPO oversubscribed 4 times on the second day, led by non-institutional investors; QIB portion least subscribed.
- Indegene IPO fully subscribed on Day 1. Check subscription, GMP and other detailsOn the first day of bidding, the initial public offering (IPO) of Indegene Ltd received a steady response, primarily fueled by strong inter...
- Indegene IPO opens for subscription. Should you bid?Indegene IPO opens for subscription with leading investors like Capital Group. Price band set at Rs 430-452. Revenue of Rs 1,969 crore and ...
- Indegene IPO opens on Monday. 10 things to know before subscribing to the issueThe IPO comprises fresh equity issue worth up to Rs 750 crore and offer for sale (OFS) of up to 2.93 crore equity shares by existing invest...
- IPO Calendar: Primary market to do away with election blues with 9 IPOs opening next weekIndegene will launch its IPO on May 6, Aadhar Housing Finance and TBO Tek on May 8. All three companies will cumulatively raise just over R...
- Indegene offers value to life sciences, needs price discoveryThe Bengaluru-based company is rolling out a ₹1,842 crore initial public offering comprising a fresh issue of ₹760 crore and an offer of sa...
- Election season, so what? IPO floodgates to stay open in MayMay's IPO frenzy continues with companies raising funds despite election season volatility. Vodafone Idea FPO oversubscribed 7 times, Bhart...
- Indegene announces price band for its Rs 1800 crore IPO. Check detailsThe company received a capital markets regulator nod in August last year. The IPO comprises fresh equity issue worth up to Rs 750 crore and...
- Indegene gets Sebi nod to float IPOThe IPO of Indegene consists of a fresh issue of equity shares worth up to Rs 950 crore and offer for sale of up to 3.63 crore equity share...
- Mamaearth's parent Honasa Consumer, healthcare tech firm Indegene get Sebi's nod to float IPOsHonasa Consumer Ltd, Indegene Ltd, and Vishnu Prakash R Punglia Ltd have received clearance from SEBI to raise funds via Initial Public Off...
- Indegene files DRHP for Rs 3,200 crore-IPOThe offer for sale comprises up to 2.7 million equity shares by individual selling shareholders including Manish Gupta, Dr. Rajesh Bhaskara...
- Carlyle Group-backed Indegene files IPO for Rs 950 cr-fresh issueExisting shareholders who are looking at selling part of their stake include Carlyle, Singapore-based venture capital fund Genesis Alternat...
- Healthcare IT firm Indegene targets $250 million in revenue by 2020, looking at Nasdaq IPOIndegene, which has been around for about 15 years, is also thinking about helping its investors monetize their investment.
Load More
